Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -5 | 0 | 0 | 5 | -4 |
| Other Working Capital | -26 | 259 | 7 | 24 | -24 |
| Other Operating Activity | 71 | -123 | -151 | -165 | -106 |
| Operating Cash Flow | $41 | $135 | $-144 | $-136 | $-134 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 60 | 0 | 222 | 0 | 0 |
| Other Financing Activity | 34 | -178 | -48 | 37 | 228 |
| Financing Cash Flow | $95 | $-178 | $175 | $37 | $228 |
| Beginning Cash Position | 20 | 63 | 32 | 131 | 37 |
| End Cash Position | 155 | 20 | 63 | 32 | 131 |
| Net Cash Flow | $135 | $-43 | $31 | $-98 | $94 |
| Free Cash Flow | |||||
| Operating Cash Flow | 41 | 135 | -144 | -136 | -134 |
| Free Cash Flow | 41 | 135 | -144 | -136 | -134 |